All Pharma News
Hart-Scott-Rodino waiting period expires for Sanofi acqu. of Provention Bio

Hart-Scott-Rodino waiting period expires for Sanofi acqu. of Provention Bio
GLOBENEWSWIRE
26 Apr 2023
Share Share
Sanofi`s Provention buy hit with FTC delay

Sanofi`s Provention buy hit with FTC delay
Angus Liu FIERCE PHARMA
11 Apr 2023
Share Share
Sanofi to acquire Provention Bio for $2.9 billion

Sanofi to acquire Provention Bio for $2.9 billion
PRESS RELEASE
14 Mar 2023
Share Share
Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release

Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release
PR NEWSWIRE
13 Mar 2023
Share Share
Provention Bio Announces the Grant of Inducement Awards

Provention Bio Announces the Grant of Inducement Awards
PR NEWSWIRE
03 Mar 2023
Share Share
Provention to Report Fourth Quarter and Full Year 2022 Financial Results

Provention to Report Fourth Quarter and Full Year 2022 Financial Results
PR NEWSWIRE
23 Feb 2023
Share Share
Provention Bio Completes $35M Equity Investment from Sanofi US

Provention Bio Completes $35M Equity Investment from Sanofi US
CONTRACT PHARMA
14 Feb 2023
Share Share
Provention Announces Completion of $35 Million Equity Investment from Sanofi US

Provention Announces Completion of $35 Million Equity Investment from Sanofi US
PR NEWSWIRE
13 Feb 2023
Share Share
Provention Bio to Present at the SVB Securities Global Biopharma Conference

Provention Bio to Present at the SVB Securities Global Biopharma Conference
PRESS RELEASE
08 Feb 2023
Share Share
Provention Bio Announces the Grant of Inducement Awards

Provention Bio Announces the Grant of Inducement Awards
PR NEWSWIRE
03 Feb 2023
Share Share